QIAGEN acquisition of BLIRT S.A.
Acquisition11/05/2022
QIAGEN announced acquisition of more than [figure hidden] of BLIRT S.A., a Polish supplier of enzymes, proteins and molecular-biology reagents. At announcement, QIAGEN intended to obtain full ownership. The transaction expanded its manufacturing capacity for its OEM business.
Type
Acquisition
Announced
11/05/2022
Amount
Financial data requires access
Reported parties
QIAGEN N.V.; BLIRT S.A.